Answer
Futibatinib (Lytgobi) should not be used during pregnancy unless the potential benefit to the woman justifies the potential risk to the foetus, as human pregnancy data are unavailable and animal studies showed embryo-foetal toxicity.
Sources for this answer
- Lytgobi 4 mg film-coated tabletsTaiho Pharma Europe Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked